A Study of Correlation between Gd-EOB-DTPA-enhanced MRI Using the 3T MRI System and Tc-99m-GSA Hepatic Scintigraphy / Hepatic Function Tests in Prehepatectomy Cases by SUYAMA Jumpei et al.
A Study of Correlation between Gd-EOB-DTPA-enhanced  
MRI Using the 3T MRI System and Tc-99m-GSA  
Hepatic Scintigraphy / Hepatic Function Tests in  
Prehepatectomy Cases
Jumpei SUYAMA1）, Akira SHINOZUKA1）, Yoshimitsu OHGIYA1）,  
Takehiko GOKAN1）, Toshiyuki BABA2）, Michio IMAWARI2）,  
Takeshi AOKI3） and Masahiko MURAKAMI3）
Abstract : This study compared results from Gd-EOB-DTPA on two different 
phases of 3T MRI with those from Tc-99m-GSA hepatic scintigraphy and 
hepatic function tests.  Twenty-four patients with liver tumor were included 
in this study.  All patients underwent Gd-EOB-DTPA-enhanced-MRI and 
Tc-99m-GSA hepatic scintigraphy.  Clearance index （HH15） and receptor 
index （LHL15） were calculated for the Tc-99m-GSA, while signal intensi-
ties （SI） of liver at pre-injection and at 4 / 20 min post-injection, and of 
spleen at 4 min / 20 min were measured （SIpre, SI4min, SI20min, SIsp4min, SIsp20min, 
respectively） for the Gd-EOB-DTPA-MRI.  Liver activity at 15 min by Tc-
99m-GSA scintigraphy or biochemical liver function values were compared 
with liver spleen contrast at 4 min （LSC4min＝SI4min / SIsp4min） or 20 min post-
injection （LSC20min＝SI4min / SISP20min）, and the increase in ratio at 4 min 
（IR4min＝SI4min / SIsp4min） or 20 min （IR20min＝SI20min / SIpre）.  Total bilirubin 
levels （T-bil）, serum albumin levels （Alb）, prothrombin activity, and the 
indocyanine green clearance test （ICG） results were also analyzed.  There 
were statistically significant correlations in all comparisons between Gd-
EOB-DTPA and Tc-99m-GSA.  The highest coefficient of correlation 
was obtained in IR4min （LHL15 : r＝0.795, P＜0.001 ; HH15 : r＝-0.782,  
P＜0.001）, with IR20min （LHL15 : r＝0.690, P＜0.01 ; HH15 : r＝-0.528,  
P＜0.05）, LSC4min （LHL15 : r＝0.458, P＜0.05 ; HH15 : r＝-0.626, P＜0.05）, 
and LSC20min （LHL15 : r＝0.443, P＜0.05, HH15 : r＝-0.609, P＜0.05） also 
signicantly correlated.  Correlations in hepatic function data were observed 
between IR4min and T-bil / Alb, and IR20min and Alb.  In 3T-MRI using Gd-
EOB-DTPA, the SI of liver at pre- to post-injection （especially at 4 min） sig-
nicantly correlated with the corresponding Tc-99m-DTPA scintigraphy results, 
and with some biochemical liver function data.
Key words : MRI, gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid 
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Introduction
　Gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid （Gd-EOB-DTPA） has been 
widely used as a magnetic resonance imaging （MRI） contrast medium for the diagnosis of 
liver tumors, including hepatoma, and its usefulness for evaluating hepatic function has been 
demonstrated by a number of studies1-4）.  Approximately 40％ of Gd-EOB-DTPA adminis-
tered to the body is excreted in bile and thus its use in the evaluation of hepatic function 
has been considered since the development of this approach.  The Child-Pugh classication 
and the uptake of ethoxybenzyl （EOB） in the liver were thus also used to conrm the 
reduction in signal enhancing effect in the hepatic parenchyma of patients with severe 
hepatic dysfunction 1-5）.
　Technetium-99m-galactosyl human serum albumin （Tc-99m-GSA） has also been used 
in the clinical setting to visually assess hepatocellular function since the rst half of 1990. 
This medium is taken up by hepatocytes via asialoglycoprotein receptors on the hepatic 
membrane and is excreted in bile.  There are various analytical methods for the evaluation 
of hepatic function using Tc-99m-GSA, with the most widely used being the clearance index 
（HH15） and the receptor index （LHL15）.  These indicators are easy to use and show 
good correlation with hepatic reserve6, 7）; they have also been used recently in postoperative 
follow-up for hepatectomy, preoperative volumetry assessment of liver remnant functions8, 9）, 
and evaluation of hepatic functions after living donor liver transplantation9, 10）.
　Both Gd-EOB-DTPA and Tc-99m-GSA are taken up by hepatocytes and excreted in 
bile, and it is therefore reasonable to assume that both could be used to evaluate hepatic 
function.  Indeed, previous comparisons of liver spleen contrast （LSC）1） as well as bile duct 
signal 11） and hepatic functions have demonstrated correlations between Gd-EOB-DTPA and 
hepatic function.  Here we tested this assumption by comparing the increase ratio （IR） 
of the liver signal / LSC when MRI was performed using Gd-EOB-DTPA with HH15 and 
LHL15 obtained using Tc-99m-GSA and hepatic function testing.  It should be noted that 
a similar previous study focused on the hepatobiliary phase1, 2）; however, the excretion to 
bile from hepatocytes differs between EOB and GSA.  We therefore assessed Gd-EOB-
DTPA-enhanced MRI both at the phase less inuenced by the excretion to bile and the 
hepatobiliary phase.
Subjects and Methods
　The subjects included 24 patients （16 males and 8 females） who underwent both pre-
operative Gd-EOB-DTPA-enhanced MRI using the 3-Tesla MRI system and Tc-99m-GSA 
hepatic scintigraphy within 1 month of admission to hospital from July 2008 to October 
2009 （interval range 1～ 30 days ; mean interval 12.8 days）.  Subject age ranged from 31 
to 78 years with a mean age of 66.0 years.  The patients’ diseases included hepatocellular 
carcinoma （n＝14）, cholangiocellular carcinoma （n＝5）, and hepatic metastases （n＝5）. 
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According to the Child-Pugh classication, 22 patients were classied as Class A, 2 as Class 
B, and none as Class C.  The primary disease of both patients classied as Class B was 
hepatocellular carcinoma.
Magnetic Resonance Imaging （MRI）
　MRI was performed using the MAGNETOME Trio A Tim System 3.0T （Siemens 
Medical Solutions, Erlangen, Germany）, with either a body-matrix-coil or spine-matrix-coil 
4ch.  The imaging sequence was VIBE with fat suppression （CHESS） （TR, 3.29 ms ; TE, 
1.22 ms ; ip angle, 13° ; FOV, 350 mm ; Matrix, 216×320 ; 56 slices ; slice thickness, 3.5 mm ; 
acquisition time, 21 s）.  The patients were instructed to fast for at least three hours or more 
before the test.  Gd-EOB-DTPA （0.025 mmol / kg body weight） was intravenously infused at 
2 ml / s, and subsequently ushed out with 20 ml of physiological saline.  Images were taken 
before, and at 4 and 20 min after injection of the contrast material.
　The signal intensity （SI） of the liver was measured in a region of interest （ROI） of 
approximately 150 mm2 in the medial and lateral segments of the left lobe, and in the ante-
rior and posterior segments of the right lobe.  The average of these values was determined 
as the signal intensity of the liver （SIL）.  The spleen SI was measured in two ROIs, at the 
anterior and posterior segments of the spleen in the same slice as that used above, and 
the average was determined as SIS.  SIL and SIS were measured before injection, and at 4 
and 20 min after contrast material injection.  Increase ratio （IR） and liver spleen contrast 
（LSC） before imaging relative to those 4 and 20 min after contrast material injection were 
calculated using the following formulae :
　IR4min＝SIL4min / SILPRE,
　IR20min＝SIL20min / SILPRE,
　LSC4min＝SIL4min / SIS4min,
　LSC20min＝SIL20min / SIS20min.
SIs of the common hepatic duct and common bile duct were measured and the mean SI 
was calculated （SIb）, as was the mean SI of the right erector spinae muscle （SIm）.  Rela-
tive SI was calculated as follows :
　Relative SI＝SIb / SIm.
99mTc-GSA scintigraphy
　The patients were instructed to fast for three hours or more before testing, and then were 
intravenously infused with 185 MBq of 99mTc-GSA, which was ushed out with 40 ml of 
physiological saline.  Images were taken using a PRISM 2000XP scintillation camera ［Philips 
（Picker）］ with a dual-head system and a low-energy high-resolution collimator.  A frontal 
view was taken in the supine position.  Serial scans were acquired with the collection matrix 
of 128×128, 15 s / frame×80 frames （20 min）.  Image processing ［Odyssey : Philips （Picker）］, 
was used to select the ROIs over the heart and liver for each time activity curve, which 
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were used to obtain the counts for the heart and liver at 3 and 15 min after the intrave-
nous infusion.  HH15 and LHL15 were calculated using the following formulae :
　HH15＝（heart count at 15 min）/（heart count at 3 min）
　LHL15＝（liver count at 15 min）/（sum of liver and heart counts at 15 min）
Statistical Analysis
　The correlation coefcients between IR4min, IR20min, LSC4min, LSC20min, HH15, and LHL15, 
and the biochemical test data including total bilirubin （T-bil）, albumin （Alb）, prothrombin 
time （PT）, ICGR15 （n＝19）, and estimated glomerular ltration rate （eGFR） were obtained. 
Signicance levels were set at P＜0.05.
Results
　The correlations among the IR of the liver signal at 4 min （IR4min） and 20 min （IR20min） 
after the infusion, the LSC at 4 min （LSC4min） and 20 min （LSC20min） after the infusion, 
and HH15 and LHL15 are shown in Fig. 1（a）-（d） and Table 1.  Signicant correlations 
were found between HH15 / LHL15 and both liver IR and LSC.  The highest correlation 
coefcient was observed between IR4min and LHL15, while the correlations of LHL15 with 
LSC4min and LSC20min were lower than those measured among the other parameters.  The 
correlation coefcient of HH15 / LHL15 with the liver IR was greater for IR4min than for 
IR20min.
　Correlations with hepatic function examination data were observed between IR4min and 
T-bil / Alb, and between IR20min and Alb, but there were no correlations for LSC4min and 
LSC20min （Table 2）.
　From the changes over time in liver SI after the infusion, the intensity 20 min after the 
infusion increased in 21 subjects （87.5％） and decreased in 3 subjects （12.5％）, compared 
with 4 min after the infusion （Fig. 2）.  The latter subjects were all classied as Class A 
according to the Child-Pugh classication.
　In this study, no visualization of contrast media inow to the bile ducts was observed at 
4 min after the infusion, while the bile ducts were visible in all cases at 20 min after the 
infusion.  There were no differences in bile duct SIs between the groups with lowered and 
increased SI in the hepatic parenchyma 20 min after the infusion.  The mean relative SI, 
excluding signal decreases at 20 min, was 4.70±1.79.  In the signal-decreased group, only one 
patient showed a higher than average SI （relative SI 7.62）; for the other two patients, SI 
was below the average value （relative SI 2.38 and 2.62, respectively）.
　In three patients, Gd-EOB-DTPA did not reach the bile duct completely, thus these cases 
were excluded from the signal-decreased group.  The primary diseases of these cases was 
hepatocellular carcinoma in one patient, hepatic metastases in one patient, and cholangiocel-
lular carcinoma in one patient, and the size was 2.8 cm, 1.8 cm, and 1.2 cm in diameter, 
respectively.  The hepatocellular carcinoma and hepatic metastases both developed in the 
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Fig. 1.　Scatter plot showing the relationship between Tc-99m-GSA and Gd-EOB-DTPA
A statistically signicant correlation was observed in all combinations.
a : HH15 and increase ratio at 4 min （IR4min, IR20min）
b : LHL15 and increase ratio （IR4min, IR20min）.
c : HH15 and liver spleen contrast （LSC4min, LSC20min）.
d : LHL15 and liver spleen contrast （LSC4min, LSC20min）.
a
b
c
d
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Table 1. Correlations between data from Gd-EOB-DTPA 
and Tc-99m-GSA, indicating a statistically signifi-
cant correlation for all combinations
LHL15 HH15
IR4 R＝0.795 （P＜0.001） R＝-0.782 （P＜0.001）
IR20 R＝0.690 （P＜0.01） R＝-0.528 （P＜0.01）
LSC4 R＝0.458 （P＜0.05） R＝-0.626 （P＜0.01）
LSC20 R＝0.433 （P＜0.05） R＝-0.607 （P＜0.01）
Table 2. Correlations between measurements and indicators of hepatic func-
tion / GFR （n＝24 ; ICG15 only n＝19）
T-bil Alb ICG15 PT GFR
LHL15
0.725
（P＜0.001）
0.456
（P＜0.05）
0.426
（n.s.）
0.313
（n.s.）
0.345
（n.s.）
HH15
0.666
（P＜0.01）
0.406
（P＜0.05）
0.487
（P＜0.05）
0.267
（n.s.）
0.260
（n.s.）
IR4min
0.532
（P＜0.05）
0.441
（P＜0.05）
0.325
（n.s.）
0.286
（n.s.）
0.243
（n.s.）
IR20min
0.224
（n.s.）
0.421
（P＜0.05）
0.141
（n.s.）
0.324
（n.s.）
0.070
（n.s.）
LSC4min
0.325
（n.s.）
0.398
（n.s.）
0.371
（n.s.）
0.062
（n.s.）
0.057
（n.s.）
LSC20min
0.392
（n.s.）
0.323
（n.s.）
0.422
（n.s.）
0.063
（n.s.）
0.131
（n.s.）
Fig. 2.　Changes in liver signal intensity over time
In three cases the signal intensity decreased from 4 minutes to 20 minutes.
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margin of the liver and there were no ndings suggesting intrahepatic biliary stenosis.  On 
the other hand, the patient with cholangiocellular carcinoma had stenosis in the intrahepatic 
bile duct of the left lobe, and contrast media inow was visualized in the intrahepatic bile 
duct of the right lobe and in part of the bile duct, but not in the intrahepatic bile duct of 
the left lobe.  IR4min of these 3 patients ranged from 1.56 to 1.85, the SI gradually increased 
up to 20 min after the infusion, and Gd-EOB-MRI revealed no distinct ndings.  The Child-
Pugh classication of these cases was Class A.  In addition, the ICG test result was slightly 
high in the patient with hepatocellular carcinoma and the patient with hepatic metastases 
（11％ and 16％, respectively）, while it was normal in the patient with cholangiocellular carci-
noma （4％）.
　When all patients in this study were divided according to the primary disease into the 
hepatocellular carcinoma group （n＝14） and non-hepatocellular carcinoma group （n＝10）, 
the correlations between IR4min and LHL15 were signicantly different at R＝0.766 （P＜
0.01） and R＝0.690 （P＜0.05）, respectively.  Dividing the non-hepatocellular carcinoma 
group further into the hepatic metastases group （n＝5） and cholangiocellular carcinoma 
group （n＝5） produced no signicant differences in the same correlation （R＝0.800 and R
＝0.719, respectively）.
Discussion
　In this study, the IR in the hepatic parenchyma before the EOB infusion, and at 4 and 
20 min after the EOB infusion, and the LSC at 4 and 20 min after the infusion were used 
as evaluation parameters of Gd-EOB-DTPA for correlative comparison with HH15 and 
LHL15 of Tc-99m-GSA and various hepatic function evaluation data.  The IR in the hepatic 
parenchyma and the LSC correlated positively with HH15 and LH15, with the coefcients 
of correlation in both cases higher at 4 min after the infusion than at 20 min after the infu-
sion.  In addition, hepatic function indicators, T-bil and Alb, correlated strongly with the IR 
in the hepatic parenchyma, but not with LSC.
　Among previous studies that evaluated hepatic function using Gd-EOB-DTPA, Motosugi 
et al 1） showed a correlation between the LSC and hepatic function, while Takao et al 11） 
reported that the relative SI ratios of skeletal muscles to the right and left hepatic ducts, 
common hepatic duct, and common bile duct delayed the rate of SI increase in patients 
with chronic liver disease, that the rate of SI increase was slower in the chronic liver 
disease group than in the normal group, and that SI signicantly correlated with ICG15. 
Finally, Nishie et al2） demonstrated that Gd-EOB-DTPA-enhanced-MRI results of liver-to-
spleen SI ratio and liver-to-major psoas muscle SI on the hepatobiliary phase were both 
well correlated with HH15 and LHL15.  Thus, Gd-EOB-DTPA-enhanced MRI is expected 
to be useful for evaluating hepatic function in a similar way to the more widely used Tc-
99m-GSA.  In general, HH15 can reect mild hepatic dysfunction and LHL15 can indicate 
severe hepatic dysfunction.  In this study, Tc-99m-GSA indicated a strong correlation with 
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LHL15 for all patients except those with severe hepatic dysfunction according to the Child-
Pugh classification.  This seemingly incompatible finding might result from the fact that 
LHL15 reects the accumulation of signal in the liver and thus has a stronger relationship 
with the rate of increase in hepatic signal.  Furthermore, the Tc-99m-GSA parameters reect 
the rate of increase in RI accumulation at 3 and 15 min.  Therefore, the IR of the liver 
signal used in this study might be pharmacokinetically more similar to Tc-99m-GSA than 
LSC, because both IR and Tc-99m-GSA directly reect uptake and excretion to hepatocytes. 
The uptake of Tc-99m-GSA in the liver may peak at 15 min after the infusion, and RI 
excretion from the hepatocytes could be ignored in the compartment model if it is only for 
30 min.  On the other hand, following the Gd-EOB-DTPA infusion, EOB was excreted in 
bile at an earlier stage than Tc-99m-GSA.  Moreover, EOB is reportedly excreted in bile by 
5 to 16 min after intravenous Gd-EOB-DTPA infusion in a normal liver 12）, suggesting that 
EOB might be taken up by the cells 4 min after the infusion and the duration recorded 
might be the phase where the excretion to bile or blood ow was inuenced less.  In addi-
tion, in terms of the changes in liver SI over time after Gd-EOB-DTPA infusion, the signal 
increased 20 min after the infusion in the majority of subjects compared with that recorded 
4 minutes after the infusion.  However, it also decreased in 3 subjects, suggesting that the 
uptake of EOB into the liver might be lower according to the evaluation of this phase 
alone.  EOB is secreted at least into the bile canaliculus and sinusoid.  As for the cause 
of the excretion from hepatocytes, the excretory pathway could undergo changes in the 
presence of vascular lesions and / or biliary tract lesions and / or the rate of excretion to the 
sinusoid or bile canaliculus could vary among individuals.  Both or either of these events 
could produce differences in the excretion of Gd-EOB-DTPA from the hepatic parenchyma, 
which is likely to influence the SI.  It remains unclear from the data why the SI was 
decreased at 20 min in some patients ; however, it was assumed that in the 3 patients with 
signal decreases at 20 min the bile duct SI was increased because of accelerated excretion of 
Gd-EOB-DTPA from the liver cells, and these intensities varied widely.  As far as we know, 
there are no reports on SIs in hepatic parenchyma or bile ducts, and further study is clearly 
needed.
　This study result indicated that the correlation coefcient between the bilirubin level and 
ICG15 was slightly higher for the Tc-99m-GSA testing compared with 3T MRI using Gd-
EOB-DTPA.  Bilirubin is synthesized in the liver and released into the bile canaliculus, and 
in animal experiments conducted to evaluate excretory capacity by Kim et al 13）, the relative 
SI value before imaging and the maximum and half maximum SI after imaging were all 
strongly correlated with the ICG15 and serum bilirubin level.  ICG, bilirubin level, and Gd-
EOB-DTPA have a common characteristic in that they are taken into the hepatic cells and 
excreted from them, which suggests that they may have similar intrahepatic kinetics.  Fur-
thermore, the relative value decreased in the patients with liver parenchymal injury caused 
by carbon tetrachloride, but did not decrease in the patients who underwent bile duct and /
85EOB-MRI and Tc-99m-GSA Scintigraphy
or portal vein ligation, which suggested that posthepatic cholestasis might have less of an 
effect on the excretion of Gd-EOB-DTPA from hepatic cells.  The study by Motosugi et al 1） 
demonstrated a strong negative correlation between the data of 20 min after EOB-MRI and 
ICG15, but no signicant correlation with the serum bilirubin level.
　The present study also found no correlation between IR20min and serum bilirubin level, 
but a signicant difference was observed with IR4min, suggesting that the shorter time after 
infusion better reected the excretory capacity of hepatic cells.  Previous literature indicates 
that ICG15 showed the strongest correlation with some biochemical liver functional data 7, 9）, 
but this study could not reproduce these ndings.  Likewise, this study showed only a slight 
correlation with HH15 when Tc-99m-GSA was used.  Factors underlying this contradic-
tion might be the low number of subjects tested for ICG15, the small population （19 / 24 
patients）, and the accuracy of the test.  However, no apparent cause could be found in the 
evaluable data and further studies are required.  Unlike bilirubin, ICG enters hepatocytes 
via receptors according to individual hepatic function before being released into the bile 
canaliculus.  Both these substances are excreted into the bile duct but are not released into 
the blood, suggesting that the kinetics were similar to those of Tc-99m-GSA.
　Three cases in this study showed no complete visualization of contrast media inflow 
to the bile ducts at 20 min after the infusion.  Takao et al 11） reported a peak SI in the 
bile ducts of normal liver at 30 min after infusion, while patients with hepatic dysfunction 
showed a peak delay and low SI.  However, neither serological hepatic dysfunction nor any 
causes of stenosis, such as stones or tumors in the bile ducts, was observed in the present 
cases without complete visualization at 20 min after the infusion.  The timing of bile excre-
tion of Gd-EOB-DTPA varies among individuals, and was earlier than the peak time of the 
contrast effect in the bile ducts.  Therefore, it was not clear whether the above-mentioned 
facts were directly reected in the impaired bile excretion.  The presence of mild cholangitis 
was suspected, although there were no effects on IR, HH15, or LHL15.
　According to primary disease, the patients with hepatocellular carcinoma in this study 
might have had liver parenchymal injury caused by hepatitis and hepatic cirrhosis.  The 
measurements were scattered, but the coefcient of correlation was slightly higher than that 
in the non-hepatocellular carcinoma group.  Among the non-hepatocellular carcinoma group, 
the correlation between results of Gd-EOB-DTPA and Tc-99m-GSA was slightly lower in 
the cholangiocellular carcinoma group than in the hepatic metastases group.  These ndings 
suggested that the presence or absence of bile duct stenosis could affect excretion from the 
hepatic parenchyma, but the majority （87.5％） of cases in this study had contrast media 
inow to the bile ducts 20 min after the infusion and this study could not elucidate whether 
liver parenchymal injury occurred.  Finally, Kim et al 13） reported that bile duct stenosis is 
less likely to inuence the excretion of Gd-EOB-DTPA.  A larger study is required to eluci-
date these points.
　A limitation of this study was that it was retrospective and in patients who were sched-
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uled to undergo hepatectomy, thus there were relatively few participants and none of Grade 
C in the Child-Pugh classication.  Nishie et al 2） reported good correlations in contrast ratio 
between the liver and iliopsoas with Tc-99m-GSA, and between the liver and spleen with 
LHL15 and HH15.  Motosugi et al 1） also reported that there were signicant correlations 
of the contrast ratios of liver and spleen with blood data.  However, the present ndings 
showed no significant correlations among LSC, Tc-99m-GSA, and blood data.  Neither 
heterogeneity of the spleen parenchyma nor apparent stenosis in the splenic artery and vein 
was observed in this study, and so the cause for these differences in study results remains 
unknown.  A larger prospective study should be performed in the future to clarify this issue, 
and to consider other timings after the infusion.
　The costs to patients and the time needed for Tc-99m-GSA and Gd-EOB-MRI are 
approximately equal in Japan.  Gd-EOB-MRI remains the standard test for hepatocellular 
carcinoma and hepatic metastases, and if the usefulness of Gd-EOB-MRI for assessing 
hepatic reserve is established, Tc-99m-GSA will no longer be used.  However, Tc-99m-GSA 
was slightly better in the relationship with the liver function data in this study and methods 
for measuring Gd-EOB-MRI vary according to the literature.  Therefore, a standard method 
of assessing hepatic reserve using Gd-EOB-MRI should be established like those used for 
Tc-99m-GSA.  Currently, Tc-99m-GSA should be the rst choice ; however, in the case of 
applying Gd-EOB-MRI alone, the method used in this study will be worthwhile in the clini-
cal setting.
　Furthermore, the results suggested that Gd-EOB-DTPA-enhanced MRI could be used to 
assess hepatic reserve by determining the increase in liver signal similar to Tc-99m-GSA.
Conclusion
　There were signicant correlations between the IR of the liver signal and the LSC as 
shown by Gd-EOB-DTPA-enhanced MRI, and between HH15 and LHL15 as demonstrated 
by Tc-99m-GSA scintigraphy.  The highest coefcient of correlation was obtained with the 
IR at 4 min, suggesting that IR of the liver signal measured by Gd-EOB-DTPA-enhanced 
MRI might be a useful parameter for evaluating hepatic function.
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